Leukemia Patients Taking Gleevec Achieve 'Normal' Death Rate Study finds they die no faster than people in the general population
Less Is More With Acute Myeloid Leukemia Drug Study finds lower doses of cytarabine as effective, with fewer side effects, as standard dose
Advertisement